Quest Diagnostics, Inc. (NYSE:DGX)

CAPS Rating: 4 out of 5

A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.

Recs

0
Player Avatar MJKpayday (99.69) Submitted: 5/29/2011 7:13:12 AM : Outperform Start Price: $57.45 DGX Score: +2.94

Price/Share - 1.4Price/Earnings - 15Price/Book - 2.6Over the last 10 years or so Quest has never traded below these multipliers. So if Quest Diagnostics performance on par with S&P500 and there is just a slight multiple expansion towards the more typical than Quest will probably be outperforming the Price of S&P.

Featured Broker Partners


Advertisement